
Shares of Thermo Fisher TMO.N are down 1.5% to $428.26 on Mon after HSBC analysts cut their PT
TMO is on track to lose ground after two consecutive sessions of gains
HSBC cut TMO PT to $540 from $560
Among 31 analysts that cover TMO, avg rating is "BUY" and median PT is $550, down from $560 a month ago
TMO is down ~18% YTD vs S&P 500 health index .SPXHC, which is down ~2%